Study of Safety and Efficacy of BZ019 in (R/R) Large B-cell Lymphoma
Clinical trial NCT04250324 · UNKNOWN
Trial details
- NCT number
- NCT04250324
- Sponsor
- Shanghai Cell Therapy Group Co.,Ltd
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-19
- Primary completion
- 2022-08-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.